Literature DB >> 26975629

Xeroderma Pigmentosum.

Jennifer O Black1.   

Abstract

Xeroderma pigmentosum (XP) is a rare disorder of defective UV-radiation induced damage repair that is characterized by photosensitivity with easy skin burning following minimal sun exposure, early freckling and development of lentiginous pigmentation along with other features of poikiloderma and a propensity for developing skin cancer at an early age. In this short review, the clinical, pathological, genetic and molecular aspects of XP are reviewed in the current literature. XP encompasses a spectrum of disease that overlaps with other diseases of DNA repair systems. In addition to cutaneous complications, patients are susceptible to eye conditions, neurodegenerative processes, central nervous system tumors and other tumors as a result of UV radiation exposure and its byproducts. Patients with XP frequently experience a shorter life span due to skin cancer and neurodegenerative sequelae, but aggressive preventative measures to minimize UV radiation exposure and damage can improve the course of disease and prolong life. The disease has served as a model for photoaging and UV radiation-induced cancer and has led to a better understanding of cell processes that prevent development of these disease features in normal individuals.

Entities:  

Keywords:  Nucleotide excision repair pathway; UV radiation; Xeroderma pigmentosum

Mesh:

Year:  2016        PMID: 26975629      PMCID: PMC4838978          DOI: 10.1007/s12105-016-0707-8

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  25 in total

1.  Genetic heterogeneity of xeroderma pigmentosum demonstrated by somatic cell hybridization.

Authors:  E A De Weerd-Kastelein; W Keijzer; D Bootsma
Journal:  Nat New Biol       Date:  1972-07-19

2.  Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair.

Authors:  J H Robbins; K H Kraemer; M A Lutzner; B W Festoff; H G Coon
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

3.  Xeroderma pigmentosum: variants with normal DNA repair and normal sensitivity to ultraviolet light.

Authors:  J E Cleaver
Journal:  J Invest Dermatol       Date:  1972-03       Impact factor: 8.551

4.  Defective repair replication of DNA in xeroderma pigmentosum.

Authors:  J E Cleaver
Journal:  Nature       Date:  1968-05-18       Impact factor: 49.962

5.  Absence of excision of ultraviolet-induced cyclobutane dimers in xeroderma pigmentosum.

Authors:  J E Cleaver; J E Trosko
Journal:  Photochem Photobiol       Date:  1970-06       Impact factor: 3.421

6.  Xeroderma pigmentosum. Clinical and laboratory investigation of its basic defect.

Authors:  W B Reed; B Landing; G Sugarman; J E Cleaver; J Melnyk
Journal:  JAMA       Date:  1969-03-17       Impact factor: 56.272

7.  Ultraviolet-stimulated thymidine incorporation in xeroderma pigmentosum lymphocytes.

Authors:  P G Burk; M A Lutzner; D D Clarke; J H Robbins
Journal:  J Lab Clin Med       Date:  1971-05

8.  Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients.

Authors:  Bernard C Broughton; Agnes Cordonnier; Wim J Kleijer; Nicolaas G J Jaspers; Heather Fawcett; Anja Raams; Victor H Garritsen; Anne Stary; Marie-Françoise Avril; Francois Boudsocq; Chikahide Masutani; Fumio Hanaoka; Robert P Fuchs; Alain Sarasin; Alan R Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

9.  Defect in DNA synthesis in skin of patients with xeroderma pigmentosum demonstrated in vivo.

Authors:  J H Epstein; K Fukuyama; W B Reed; W L Epstein
Journal:  Science       Date:  1970-06-19       Impact factor: 47.728

10.  Evidence that xeroderma pigmentosum cells do not perform the first step in the repair of ultraviolet damage to their DNA.

Authors:  R B Setlow; J D Regan; J German; W L Carrier
Journal:  Proc Natl Acad Sci U S A       Date:  1969-11       Impact factor: 11.205

View more
  23 in total

Review 1.  Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms.

Authors:  Rosella Abeti; Anna Zeitlberger; Colm Peelo; Hiva Fassihi; Robert P E Sarkany; Alan R Lehmann; Paola Giunti
Journal:  Br J Pharmacol       Date:  2019-01-23       Impact factor: 8.739

Review 2.  Therapeutics of xeroderma pigmentosum: A PRISMA-compliant systematic review.

Authors:  Fernando Antônio Gomes de Andrade; Claudio Eduardo de Oliveira Cavalcanti; Felipe Contoli Isoldi; Lydia Masako Ferreira
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Mar-Apr       Impact factor: 2.545

Review 3.  DNA repair fidelity in stem cell maintenance, health, and disease.

Authors:  Chinnadurai Mani; P Hemachandra Reddy; Komaraiah Palle
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-04-04       Impact factor: 5.187

Review 4.  DNA repair, recombination, and damage signaling.

Authors:  Anton Gartner; JoAnne Engebrecht
Journal:  Genetics       Date:  2022-02-04       Impact factor: 4.402

Review 5.  Xeroderma pigmentosum: an updated review.

Authors:  Alexander Kc Leung; Benjamin Barankin; Joseph M Lam; Kin Fon Leong; Kam Lun Hon
Journal:  Drugs Context       Date:  2022-04-25

Review 6.  DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome.

Authors:  Kristyna Tomasova; Andrea Cumova; Karolina Seborova; Josef Horak; Kamila Koucka; Ludmila Vodickova; Radka Vaclavikova; Pavel Vodicka
Journal:  Cancers (Basel)       Date:  2020-06-28       Impact factor: 6.639

Review 7.  Biomarkers of Cellular Senescence and Skin Aging.

Authors:  Audrey S Wang; Oliver Dreesen
Journal:  Front Genet       Date:  2018-08-23       Impact factor: 4.599

Review 8.  Interplay between BRCA1 and GADD45A and Its Potential for Nucleotide Excision Repair in Breast Cancer Pathogenesis.

Authors:  Sylwia Pietrasik; Gabriela Zajac; Jan Morawiec; Miroslaw Soszynski; Michal Fila; Janusz Blasiak
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

9.  Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients.

Authors:  Lauren G Aoude; Vanessa F Bonazzi; Sandra Brosda; Kalpana Patel; Lambros T Koufariotis; Harald Oey; Katia Nones; Scott Wood; John V Pearson; James M Lonie; Melissa Arneil; Victoria Atkinson; B Mark Smithers; Nicola Waddell; Andrew P Barbour
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.379

Review 10.  Cutaneous Papillomaviruses and Non-melanoma Skin Cancer: Causal Agents or Innocent Bystanders?

Authors:  Daniel Hasche; Sabrina E Vinzón; Frank Rösl
Journal:  Front Microbiol       Date:  2018-05-02       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.